Harpel James W – ‘SC 13G’ on 1/7/10 re: Cleveland Biolabs Inc

On:  Thursday, 1/7/10, at 4:32pm ET   ·   Accession #:  902664-10-14   ·   File #:  5-82030

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Cleveland Biolabs, Inc.                                6     21K 

Document Table of Contents

SC 13G
1st Page of 6
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

 Under the Securities Exchange Act of 1934

 Cleveland BioLabs, Inc.
(Name of Issuer)

Common Stock, par value $0.005 per share
(Title of Class of Securities)

 185860103
(CUSIP Number)

 December 31, 2009
 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:                                                              
[ ]  Rule 13d-1(b)                                                    
[X]  Rule 13d-1(c)                                                    
[ ]  Rule 13d-1(d)                                                    

----------------                                                                
*The remainder of this cover page shall be filled out for a reporting 
person's initial filing on this form with respect to the subject class of       
securities, and for any subsequent amendment containing information which would 
alter the disclosures provided in a prior cover page.                           

   The information required in the remainder of this cover page shall not be
deemed to be "filed" for purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

 Page 1 of 6 Pages

SC 13G
2nd Page of 6
TOC
1st
Previous
Next
↓Bottom
Just 2nd
CUSIP No. 185860103              13G                  Page 2 of 6 Pages         

-----------------------------------------------------------------------         
(1) NAMES OF REPORTING PERSONS                                        

James W. Harpel                                               
-----------------------------------------------------------------------         
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                  
(see instructions)                                            
                                                       (a) [ ]
                                                       (b) [ ]
-----------------------------------------------------------------------         
(3) SEC USE ONLY                                                      
-----------------------------------------------------------------------         
(4) CITIZENSHIP OR PLACE OF ORGANIZATION                              

United States                                                 
-----------------------------------------------------------------------         
NUMBER OF      (5)  SOLE VOTING POWER                                           
1,109,118                               
SHARES         --------------------------------------------------------         

BENEFICIALLY   (6)  SHARED VOTING POWER                                         
0                                       
OWNED BY       --------------------------------------------------------         

EACH           (7)  SOLE DISPOSITIVE POWER                                      
1,122,618                               
REPORTING      --------------------------------------------------------         

PERSON WITH    (8)  SHARED DISPOSITIVE POWER                                    
0                                       
-----------------------------------------------------------------------         
(9)     AGGREGATE AMOUNT BENEFICIALLY OWNED                           
BY EACH REPORTING PERSON                              
1,122,618                                             
-----------------------------------------------------------------------         
(10)    CHECK BOX IF THE AGGREGATE AMOUNT                             
IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) 
                                                           [ ]
-----------------------------------------------------------------------         
(11)    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)             
5.3%                                                  
-----------------------------------------------------------------------         
(12)    TYPE OF REPORTING PERSON (see instructions)                   
IN                                                    
-----------------------------------------------------------------------         

SC 13G
3rd Page of 6
TOC
1st
Previous
Next
↓Bottom
Just 3rd
CUSIP No. 185860103              13G                  Page 3 of 6 Pages         

Item 1.                                                                         

(a)  Name of Issuer                                                             

       Cleveland BioLabs, Inc., a Delaware corporation (the "Company")

(b)  Address of Issuer's Principal Executive Offices                            

73 High Street, Buffalo                                 
New York 14203                                          

Item 2(a).  Name of Person Filing                                               

James W. Harpel (the "Reporting Person")                

Item 2(b).  Address of Principal Business Office                                

1102 North Ocean Boulevard                              
Palm Beach, Florida 33480                               

Item 2(c).  Citizenship                                                         

United States                                           

Item 2(d)   Title of Class of Securities                                        

 Common Stock, par value $0.005 per share ("Common Stock")

Item 2(e)   CUSIP Number                                                        

185860103                                               

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or   
(c), check whether the person filing is a:                                    

(a) [ ]  Broker or dealer registered under Section 15 of the Act (15 U.S.C.     
78o).                                                         

(b) [ ]  Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).         

(c) [ ]  Insurance company as defined in Section 3(a)(19) of the Act (15        
U.S.C. 78c).                                                  

(d) [ ]  Investment company registered under Section 8 of the Investment        
Company Act of 1940 (15 U.S.C. 80a-8).                        

(e) [ ]  An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);      

(f) [ ]  An employee benefit plan or endowment fund in accordance with Rule     
13d-1(b)(1)(ii)(F);                                           

(g) [ ]  A parent holding company or control person in accordance with Rule     
13d-1(b)(1)(ii)(G);                                           

(h) [ ]  A savings association as defined in Section 3(b) of the Federal        
Deposit Insurance Act (12 U.S.C. 1813);                       

SC 13G
4th Page of 6
TOC
1st
Previous
Next
↓Bottom
Just 4th
CUSIP No. 185860103              13G                  Page 4 of 6 Pages         

(i) [ ]  A church plan that is excluded from the definition of an investment    
      company under Section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3);                                            

(j) [ ]  Group, in accordance with Rule 13d-1(b)(1)(ii)(J).                     

If this statement is filed pursuant to Rule 13d-1(c), check this box. [X]       

Item 4.   Ownership                                                             

            Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.       

(a) Amount beneficially owned:                          

          As of the date of this filing, the Reporting Person beneficially
owns 1,122,618 shares of Common Stock, including 190,543 shares of Common Stock,
(of which 37,200 shares of Common Stock are held in trust for the benefit of    
certain of the Reporting Person's children and grandchildren), 392,858 shares of
Common Stock issuable upon exercise of the Company's Series D warrants (the     
"Warrants") (of which Warrants to purchase 78,572 shares of Common Stock are    
held in trust for the benefit of certain of the Reporting Person's children) and
539,217 shares of Common Stock issuable upon conversion of the Company's Series 
D shares of preferred stock (the "Preferred Stock") (of which shares of         
Preferred Stock convertible into 107,844 shares of Common Stock are held in     
trust for the benefit of certain of the Reporting Person's children). The       
Reporting Person only has dispositive power with respect to the 13,500 shares of
Common Stock held in trusts for his grandchildren, but does not have voting     
power with respect to such shares of Common Stock. Pursuant to the terms of the 
Warrants and the shares of Preferred Stock (as set forth in the Company's       
Certificate of Designation of Preferences, Rights and Limitations of the        
Preferred Stock), the Reporting Person cannot convert or exercise any of the    
Warrants or shares of Preferred Stock until such time as the Reporting Person   
would not beneficially own, after any such exercise or conversion, more than    
9.99% of the outstanding shares of Common Stock.                                

(b) Percent of class:                                   

 The Company informed the Reporting Person in writing that as of
December 31, 2009, there were 20,203,508 shares of Common Stock outstanding.    
Therefore, based on the Company's total outstanding shares of Common Stock and  
assuming exercise of the reported Warrants and shares of Preferred Stock, the   
Reporting Person may be deemed to beneficially own 5.3% of the outstanding      
shares of Common Stock of the Company.                                          

(c) Number of shares as to which such person has:       

(i)   Sole power to vote or to direct the vote  

0                                   

(ii)  Shared power to vote or to direct the vote

See Item 4(a)                       

           (iii) Sole power to dispose or to direct the disposition of

SC 13G
5th Page of 6
TOC
1st
Previous
Next
↓Bottom
Just 5th
CUSIP No. 185860103              13G                  Page 5 of 6 Pages         

0                                   

             (iv)  Shared power to dispose or to direct the disposition of

See Item 4(a)                       

Item 5.  Ownership of Five Percent or Less of a Class                           

Not applicable.                                               

Item 6.  Ownership of More than Five Percent on Behalf of Another Person        

Not applicable.                                               

Item 7.  Identification and Classification of the Subsidiary Which Acquired     
 the Security Being Reported on by the Parent Holding Company or
Control Person                                                

Not applicable.                                               

Item 8.  Identification and Classification of Members of the Group              

See Exhibit I.                                                

Item 9.  Notice of Dissolution of Group                                         

Not applicable.                                               

Item 10. Certification                                                          

      By signing below each of the undersigned certifies that, to the best
of its knowledge and belief, the securities referred to above were not acquired 
and are not held for the purpose of or with the effect of changing or           
influencing the control of the issuer of the securities and were not acquired   
and are not held in connection with or as a participant in any transaction      
having that purpose or effect.                                                  

SC 13G
Last Page of 6
TOC
1st
Previous
Next
↓Bottom
Just 6th
CUSIP No. 185860103              13G                  Page 6 of 6 Pages         

SIGNATURES

     After reasonable inquiry and to the best of its knowledge and
belief, each of the undersigned certifies that the information with respect to  
it set forth in this statement is true, complete, and correct.                  

Dated: January 7, 2010                                                          

/s/ James W. Harpel                                                             
--------------------------                                                      
JAMES W. HARPEL                                                                 

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘SC 13G’ Filing		Date		First		Last			Other Filings
Filed on:		1/7/10		6
		12/31/09		1		4			10-K
									List all Filings